Por: RTTNews Health December 18, 2023
Viridian Therapeutics, Inc. () announced the selection of VRDN-003 as the company's lead subcutaneous program for thyroid eye disease based on positive data from a Phase 1 clinical study in healthy volunteers. The data showed that VRDN-003 has an extended half-life of 40-50 days, about 4-5 times longer than VRDN-001 and based upon comparisons of publicly disclosed data, significantly longer than other first generation anti-insulin-like... + full article
RTTNews USA Health December 07, 2023
Life sciences company Solid Biosciences Inc. () announced Thursday that it has received Fast Track Designation from the U.S. Food and Drug Administration (FDA) for SGT-003, the company's next-generation Duchenne muscular dystrophy gene therapy candidate.IND clearance by the... + más
High school scores and top performers from Friday, March 24 | Orlando Sentinel
High school scores and top performers from Tuesday, March 28 | Orlando Sentinel
RTTNews USA Health November 27, 2023
Biopharmaceutical company Outlook Therapeutics, Inc. () announced Monday the receipt of the official minutes from the Type A meeting with the U.S. Food and Drug Administration (FDA) held in October 2023.The type A meeting was regarding the Complete Response Letter (CRL) dated... + más
Protalix Resubmits To FDA The BLA For Pegunigalsidase Alfa For Treatment Of Fabry Disease | RTTNews
Sarepta Therapeutics Updates Of BLA For Sarepta's Duchenne Muscular Dystrophy Drug Candidate | RTTNews
ABC News USA Business July 11, 2023
NEW YORK -- Stocks that are trading heavily or have substantial price changes on Tuesday.E2open Parent Holdings Inc. (ETWO), up 2 cents to $5.71. The maker of supply chain management software reported solid fiscal first-quarter financial results.WD-40 Co. (WDFC), up $35.08 to... + más
One Of The Most Useful Tools For Cannabis Investors And Entrepreneurs Goes Online After 8 Years Of Exclusive Email Access | Forbes
Is the cannabis gold rush over? Moves by Curaleaf, Ayr, Akerna and other companies point to tough times. | MarketWatch
MarketWatch USA Business June 17, 2023
Sarissa Capital issued a press release on June 13 urging Alkermes shareholders to vote for its board nominees at Alkermes’ June 29 shareholders meeting. Sarissa believes representation is needed given the company’s poor performance over the years, as it believes Chairman and... + más
NFL Playoff Scenarios | ABC News
Le Krewe du Roi celebrates the state at 58th annual Mardi Gras Ball | The Advocate
Forbes USA Life February 23, 2023
Viridian Deal TrackerJavier Hasse As the cannabis industry continues to expand, businesses need to keep a close eye on new product types and trends, form factors and pricing to stay competitive. Sales and product data sets from top analytics firms like BDSA, Headset, Eaze or... + más
Report: Cannabis Ranks The 6th Most Valuable Crop In The U.S. | Forbes
Adult-Use Cannabis In Illinois Created 30,000 Jobs, Governor J.B. Pritzker Says | Forbes
MarketWatch USA Business January 30, 2023
The cooler prospects for cannabis companies, along with the overall bear market that took hold in 2022, have caused merger-and-acquisition activity in the cannabis sector to drop by 73.6%, to $10.2 billion for the 12 months ending Jan. 27, according to estimates published Monday... + más
Ascend Wellness, Ayr post wider losses as revenue climbs | MarketWatch
What Are the Duties of A Trustee? | Forbes
The Boston Globe USA Nation December 29, 2022
A new coronavirus variant dubbed XBB has swiftly spreading in the Northeast, jumping from about 35 percent of cases during the week ending Dec. 17 to just over half of cases last week, according to .Here’s a quick primer on what we know about the variant.It is more... + más
Highly Immune Evasive Omicron XBB.1.5 Variant Is Quickly Becoming Dominant in U.S. as It Doubles Weekly | NBC 6 South Florida
Highly immune evasive omicron XBB.1.5 variant is quickly becoming dominant in U.S. as it doubles weekly | CNBC
About iurex | Privacy Policy | Disclaimer |